OA reduced the invasion and migration of both HUVECs and HCT-116 colorectal cancer by blocking phosphorylation or lowering the level of vascular endothelial growth factor receptor-2 (VEGFR2) via the inhibition of MEK/ERK/JNK pathway [96]. Here, KDR is linked to colorectal cancer.